A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

Allison Ciaccio had a respiratory illness that wouldn't go away. Repeated follow-ups found Stage I lung cancer.

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...

The fourth edition of Bronchus 2025, an Interventional Pulmonology Conference, brought together medical experts from across the globe to discuss advancements in lung health and treatment ...

A recent study found that structured cessation programs improve quit rates among lung cancer screening participants. How can physicians leverage this?

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Willis Knighton Cancer Center celebrate groundbreaking research on radiation therapy. According to Willis Knighton, physicist ...